Regulatory News for March 2013

Regulatory News Archive

FDA adds heart risk warning to popular antibiotic Zithromax FDA adds heart risk warning to popular antibiotic Zithromax

The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.

Government prepares to act to attract drug research projects back to the UK, says Withers & Rogers Government prepares to act to attract drug research projects back to the UK, says Withers & Rogers

The Government is preparing to take action to attract drug research projects back to the UK by ensuring that patent laws are consistent with those in most other EU member states, according to Withers & Rogers – one of the UK’s leading firms of patent and trade mark attorneys.